We are live on ! Find out more
MC

Maverick Capital Portfolio holdings

AUM $8.67B
1-Year Est. Return 48.76%
This Fund
S&P 500
This Quarter Est. Return
+0.99%
1 Year Est. Return
+48.76%
3 Year Est. Return
+198.74%
5 Year Est. Return
+110.99%
10 Year Est. Return
+397.6%
AUM
$8.85B
AUM Growth
-$1.07B
Cap. Flow
-$1.02B
Cap. Flow %
-11.52%
Top 10 Hldgs %
56.72%
Holding
681
New
56
Increased
52
Reduced
179
Closed
373

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 43.56%
2 Technology 17.09%
3 Healthcare 11.19%
4 Communication Services 9.35%
5 Financials 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRIS icon
51
Curis
CRIS
$9.71M
$37.1M 0.42%
19,476
+532
+3% +$1.27M
CCC
52
CCC Intelligent Solutions
CCC
$3.55B
$35.7M 0.4%
3,137,836
CMAX
53
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$33.2M 0.37%
143,889
+14
+0% +$3.33K
FND icon
54
Floor & Decor
FND
$6.03B
$33.1M 0.37%
254,489
+5,980
+2% +$770K
INST
55
DELISTED
Instructure Holdings, Inc.
INST
$30.4M 0.34%
1,269,500
+19,500
+2% +$472K
HCP
56
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$29.6M 0.33%
+325,000
New +$28.3M
DGNU
57
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$29.3M 0.33%
3,000,000
CFLT
58
DELISTED
Confluent
CFLT
$27.3M 0.31%
358,030
+8,030
+2% +$579K
OHPAU
59
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$26.3M 0.3%
2,672,349
DDOG icon
60
Datadog
DDOG
$94B
$24.6M 0.28%
+137,940
New +$23.4M
DECK icon
61
Deckers Outdoor
DECK
$14.1B
$24M 0.27%
392,400
-53,370
-12% -$3.44M
JWSM
62
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$23.2M 0.26%
2,381,170
MTCH icon
63
Match Group
MTCH
$9.19B
$21M 0.24%
158,830
+131,737
+486% +$19.1M
ASML icon
64
ASML
ASML
$596B
$17.8M 0.2%
22,309
+638
+3% +$507K
WVE icon
65
Wave Life Sciences
WVE
$1.12B
$17.6M 0.2%
5,593,389
+2,400,000
+75% +$9.97M
PRVA icon
66
Privia Health
PRVA
$3.04B
$15.6M 0.18%
604,908
+104,908
+21% +$2.62M
MSDAU
67
DELISTED
MSD Acquisition Corp. Unit
MSDAU
$15.2M 0.17%
1,500,000
AGCB
68
DELISTED
Altimeter Growth Corp 2
AGCB
$14.6M 0.16%
1,478,793
PANA
69
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$13.4M 0.15%
1,385,250
GTACU
70
DELISTED
Global Technology Acquisition Corp. I Unit
GTACU
$12.1M 0.14%
+1,200,000
New +$12.1M
PHIC
71
DELISTED
Population Health Investment Co., Inc. Class A Ordinary Share
PHIC
$11.7M 0.13%
1,185,260
NVSAU
72
DELISTED
New Vista Acquisition Corp Unit
NVSAU
$9.91M 0.11%
991,224
RKTA.U
73
DELISTED
Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RKTA.U
$9.84M 0.11%
989,520
CRBU icon
74
Caribou Biosciences
CRBU
$146M
$9.75M 0.11%
652,542
-300,000
-31% -$5.83M
SQZ
75
DELISTED
SQZ Biotechnologies Company
SQZ
$9.44M 0.11%
1,056,786

Similar funds

Maverick Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Maverick Capital held 681 positions worth $8.85B, down 11% from $9.92B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Maverick Capital withdrew a net $1.02B in Q4 2021, closing 373 positions and reducing 179 holdings. Its most notable exit was Centene, an estimated $257M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Maverick Capital opened a new position in Rivian worth $51.8M.

  • Maverick Capital's largest Q4 2021 buy was Rivian: 500,000 shares worth $51.8M.
  • Maverick Capital added most to Oak Street Health, Inc. in Q4 2021, an estimated $150M increase.
  • Maverick Capital's biggest Q4 2021 reduction was Coupang, cutting an estimated $279M.
  • Maverick Capital fully exited Centene in Q4 2021, selling an estimated $257M.
  • Maverick Capital's ten largest holdings make up 57% of its $8.85B portfolio in Q4 2021.
  • Maverick Capital opened 56 new positions and closed 373 in Q4 2021.
  • Maverick Capital's portfolio value fell 11% quarter-over-quarter to $8.85B.

Based on Maverick Capital's 13F filing for Q4 2021, filed 14 Feb 2022.